These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26768567)

  • 1. Statistical considerations for a trial of Ebola virus disease therapeutics.
    Proschan MA; Dodd LE; Price D
    Clin Trials; 2016 Feb; 13(1):39-48. PubMed ID: 26768567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial design for evaluating novel treatments during an outbreak of an infectious disease.
    Whitehead J; Olliaro P; Lang T; Horby P
    Clin Trials; 2016 Feb; 13(1):31-8. PubMed ID: 26768556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response.
    Berry SM; Petzold EA; Dull P; Thielman NM; Cunningham CK; Corey GR; McClain MT; Hoover DL; Russell J; Griffiss JM; Woods CW
    Clin Trials; 2016 Feb; 13(1):22-30. PubMed ID: 26768569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges.
    Kennedy SB; Neaton JD; Lane HC; Kieh MW; Massaquoi MB; Touchette NA; Nason MC; Follmann DA; Boley FK; Johnson MP; Larson G; Kateh FN; Nyenswah TG
    Clin Trials; 2016 Feb; 13(1):49-56. PubMed ID: 26768572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of Ebola Therapeutics During the 2014-2015 Outbreak.
    Mendoza EJ; Qiu X; Kobinger GP
    Trends Mol Med; 2016 Feb; 22(2):164-173. PubMed ID: 26774636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trials in the West African Ebola virus outbreak.
    Upshur R; Fuller J
    Clin Trials; 2016 Feb; 13(1):10-2. PubMed ID: 26768558
    [No Abstract]   [Full Text] [Related]  

  • 7. The Past Need Not Be Prologue: Recommendations for Testing and Positioning the Most-Promising Medical Countermeasures for the Next Outbreak of Ebola Virus Infection.
    Davey RT; Dodd L; Proschan M; Jahrling P; Hensley L; Higgs E; Lane HC
    J Infect Dis; 2018 Nov; 218(suppl_5):S690-S697. PubMed ID: 30032267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral therapeutics for the treatment of Ebola virus infection.
    Cardile AP; Downey LG; Wiseman PD; Warren TK; Bavari S
    Curr Opin Pharmacol; 2016 Oct; 30():138-143. PubMed ID: 27639220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.
    ; ; Davey RT; Dodd L; Proschan MA; Neaton J; Neuhaus Nordwall J; Koopmeiners JS; Beigel J; Tierney J; Lane HC; Fauci AS; Massaquoi MBF; Sahr F; Malvy D
    N Engl J Med; 2016 Oct; 375(15):1448-1456. PubMed ID: 27732819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ebola therapy for patients with Ebola virus disease: a systematic review.
    Lee JS; Adhikari NKJ; Kwon HY; Teo K; Siemieniuk R; Lamontagne F; Chan A; Mishra S; Murthy S; Kiiza P; Hajek J; Bah EI; Lamah MC; Kao R; Fowler RA
    BMC Infect Dis; 2019 May; 19(1):376. PubMed ID: 31046707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nubia's mother: being pregnant in the time of experimental vaccines and therapeutics for Ebola.
    Caluwaerts S
    Reprod Health; 2017 Dec; 14(Suppl 3):157. PubMed ID: 29297408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: Statistical considerations, design rationale, and challenges.
    Vandebosch A; Mogg R; Goeyvaerts N; Truyers C; Greenwood B; Watson-Jones D; Herrera-Taracena G; Parys W; Vangeneugden T
    Clin Trials; 2016 Feb; 13(1):57-65. PubMed ID: 26768568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
    Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna ; Kighoma PM; Koundouno FR; Réné Lolamou ; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; Wölfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; Günther S; de Lamballerie X; Keïta S; Mentre F; Anglaret X; Malvy D;
    PLoS Med; 2016 Mar; 13(3):e1001967. PubMed ID: 26930627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious diseases. Ebola drug trials lurch ahead.
    Kupferschmidt K; Cohen J
    Science; 2015 Feb; 347(6223):701-2. PubMed ID: 25678637
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of ebola virus disease.
    Kilgore PE; Grabenstein JD; Salim AM; Rybak M
    Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease Outbreak.
    Higgs ES; Dubey SA; Coller BAG; Simon JK; Bollinger L; Sorenson RA; Wilson B; Nason MC; Hensley LE
    Curr Top Microbiol Immunol; 2017; 411():229-261. PubMed ID: 28918539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection.
    Wu W; Liu S
    Curr Top Med Chem; 2017; 17(3):361-370. PubMed ID: 27572081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing an Ebola Vaccine Study - Sierra Leone.
    Widdowson MA; Schrag SJ; Carter RJ; Carr W; Legardy-Williams J; Gibson L; Lisk DR; Jalloh MI; Bash-Taqi DA; Kargbo SA; Idriss A; Deen GF; Russell JB; McDonald W; Albert AP; Basket M; Callis A; Carter VM; Ogunsanya KR; Gee J; Pinner R; Mahon BE; Goldstein ST; Seward JF; Samai M; Schuchat A
    MMWR Suppl; 2016 Jul; 65(3):98-106. PubMed ID: 27387395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study.
    Dodd LE; Proschan MA; Neuhaus J; Koopmeiners JS; Neaton J; Beigel JD; Barrett K; Lane HC; Davey RT
    J Infect Dis; 2016 Jun; 213(12):1906-13. PubMed ID: 26908739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The link between the West African Ebola outbreak and health systems in Guinea, Liberia and Sierra Leone: a systematic review.
    Shoman H; Karafillakis E; Rawaf S
    Global Health; 2017 Jan; 13(1):1. PubMed ID: 28049495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.